Concorde Asset Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-404
Closed -$229K 227
2025
Q4
$229K Buy
+404
New +$215K 0.09% 205
2025
Q1
Sell
-554
Closed -$289K 186
2024
Q4
$289K Buy
554
+97
+21% +$50.5K 0.15% 131
2024
Q3
$225K Sell
457
-8
-2% -$3.72K 0.13% 152
2024
Q2
$207K Sell
465
-432
-48% -$172K 0.13% 149
2024
Q1
$358K Sell
897
-15
-2% -$5.67K 0.24% 74
2023
Q4
$308K Sell
912
-52
-5% -$15.5K 0.21% 108
2023
Q3
$282K Buy
964
+230
+31% +$71.8K 0.25% 97
2023
Q2
$251K Buy
+734
New +$222K 0.23% 95
2022
Q2
Sell
-981
Closed -$296K 141
2022
Q1
$296K Sell
981
-969
-50% -$283K 0.2% 110
2021
Q4
$701K Sell
1,950
-195
-9% -$67.1K 0.42% 87
2021
Q3
$711K Buy
2,145
+1,020
+91% +$343K 0.41% 86
2021
Q2
$345K Sell
1,125
-441
-28% -$124K 0.19% 124
2021
Q1
$386K Sell
1,566
-4,392
-74% -$1.1M 0.22% 114
2020
Q4
$1.63M Buy
+5,958
New +$1.48M 0.9% 30

Other funds holding ISRG

Concorde Asset Management's ISRG Position: Q1 2026 in Review

Concorde Asset Management sold out of Intuitive Surgical (ISRG) in Q1 2026, closing a stake of 404 shares — an estimated $229K sold.

Concorde Asset Management first reported a position in ISRG in Q4 2020 and held it in 14 quarters. The position peaked at $1.63M in Q4 2020. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Concorde Asset Management reported no remaining Intuitive Surgical position as of Q1 2026 after selling out during the quarter.
  • Concorde Asset Management sold 404 Intuitive Surgical shares in Q1 2026, an estimated $229K.
  • Concorde Asset Management first reported a position in Intuitive Surgical in Q4 2020 and held it in 14 quarters.
  • Concorde Asset Management's Intuitive Surgical position peaked at $1.63M in Q4 2020.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Concorde Asset Management's 13F filing for Q1 2026, filed 1 Jun 2026.